Clinical Trial: A Study to Evaluate the Efficacy and Safety of CHF10196 Tablets (Florensocatib) Compared With Placebo in Male and Female Participants 12 to 85 Years of Age With Bronchiectasis

U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07577804) titled 'A Study to Evaluate the Efficacy and Safety of CHF10196 Tablets (Florensocatib) Compared With Placebo in Male and Female Participants 12 to 85 Years of Age With Bronchiectasis' on April 27.

Brief Summary: This study aims to find out whether the tablet CHF10196 is safe and effective for people with non-cystic fibrosis bronchiectasis, a long-term lung disease that causes widened airways, mucus build-up, infections, and flare-ups of symptoms. The main goal is to see whether CHF10196 can reduce the number of lung flare-ups each year compared with placebo. The study will also assess whether it can improve lung function, quality of life, a...